NED-260 COVID is the Critical Missing Piece of the COVID-19 Therapy Puzzle
The novel coronavirus pandemic has gripped the world in a medical and economic crisis. As a response to the COVID-19 pandemic, we, at NED Biosystems, are working to seek approval for a safe, oral treatment/prophylaxis for populations globally. This new COVID-19 product may provide a double benefit to:
- prevent disease progression for those afflicted, and
- protect those who are exposed to COVID-19 from viral infection.
This new product could allow COVID-19 patients to recover safely at home and avoid hospitalization. For economically challenged global populations, NED-260 COVID requires no sophisticated infrastructure or cold chain management.
Learn more about NED-260 COVID and the science behind this transformative new treatment.